Boston, MA 03\/05\/2014 (wallstreetpr) – Halozyme Therapeutics, Inc. (NASDAQ:HALO)<\/b>, the $1.82 billion market capped biopharma company was a mover in the last session. Shares of the company were a source of excitement, rising 8.16 percent to $14.97. The shares managed to dance between $14.09 and $15 on the day which saw a fairly large volume of shares changing hands. Halozyme Therapeutics, Inc. (NASDAQ:HALO) recently reported fourth quarter and fiscal 2013 financial performance. In summary, the company generated revenue of $12.5 million and net loss of $22 million, translating to loss of 19 cents per share. That was in the fourth quarter. That compared with revenue of $21.8 million and net loss of $4.4 million, reflecting 4 cents loss per share in the fourth quarter a year ago. As for the full year, revenue was $54.8 million and net loss of $83.5 million, translating to loss of 74 cents per share. In the prior year, Halozyme Therapeutics, Inc. (NASDAQ:HALO) registered revenue of $42.3 million and net loss came in at $53.6 million, meaning 48 cents per share.<\/p>\n
InvenSense Inc (NYSE:INVN)<\/b> was breaking away from the past in the last session. The stock was last seen trading at $22.25, having registered 8.11 percent gain. It was a day that INVN wrote new one-year high on its stock at $22.46. Through the day, the stock touched a low of $20.57. The estimates around INVN have been adjusted in the last 7 days. Investment experts at Topeka Capital Market raised their price target on the stock to $25 from $21 in their note published Tuesday. The price assigned the stock by Topeka Capital Markets indicates upside potential of about 21.48 percent from the prevailing price. Several analysts have also issued their view on the stock recently, thus resulting in consensus rating of \u201cbuy\u201d and average price target of $22.10. InvenSense Inc (NYSE:INVN) recently posted earnings that beat estimates.<\/p>\n
China CGame Inc (OTCMKTS:CCGM)<\/b><\/b> lacked momentum and excitement in the last session. The stock traded flat in the last trading day. However, it was able to register some upward swings that could not be maintained. CCGM had its stock touching a high of $0.10 and low of $0.07. In the past one year CCGM has traded its stock between $0.01 and $0.25. China CGame Inc (OTCMKTS:CCGM), <\/b>with market cap at $1.36 million, had nearly half the normal daily volume of shares changing hands in the last session.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 03\/05\/2014 (wallstreetpr) – Halozyme Therapeutics, Inc. (NASDAQ:HALO), the $1.82 billion market capped biopharma company was a mover in the last session. Shares of […]<\/p>\n","protected":false},"author":12,"featured_media":16576,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,4085],"tags":[4875,4873,3994,4874,3995,4876],"stock_ticker":[],"class_list":["post-16562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-analyst-reports-on-stocks","tag-china-cgame-inc-otcmktsccgm","tag-halozyme-therapeutics-inc-nasdaqhalo","tag-invensense-inc-nyseinvn","tag-nasdaqhalo","tag-nyseinvn","tag-otcmktsccgm","entry"],"acf":[],"yoast_head":"\n